BRIGHTCOVE(NASDAQ:BCOV) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to BCOV. BCOV was compared to 82 industry peers in the IT Services industry. While BCOV seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, BCOV is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

BCOV had positive earnings in the past year.

BCOV had a positive operating cash flow in the past year.

BCOV had negative earnings in 4 of the past 5 years.

In the past 5 years BCOV always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of BCOV (-4.34%) is comparable to the rest of the industry.

BCOV has a Return On Equity (-9.58%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-4.34%
ROE	-9.58%
ROIC	N/A

ROA(3y)-4.02%

ROA(5y)-5.56%

ROE(3y)-9.19%

ROE(5y)-12.88%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BCOV has a better Gross Margin (61.60%) than 81.01% of its industry peers.

BCOV's Gross Margin has been stable in the last couple of years.

BCOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	61.6%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.06%

GM growth 5Y0.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, BCOV has more shares outstanding

The number of shares outstanding for BCOV has been increased compared to 5 years ago.

BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 0.08, we must say that BCOV is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.08, BCOV is not doing good in the industry: 83.54% of the companies in the same industry are doing better.

There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	0.08

ROIC/WACCN/A

WACC10.73%

2.3 Liquidity

BCOV has a Current Ratio of 0.75. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.75, BCOV is doing worse than 88.61% of the companies in the same industry.

BCOV has a Quick Ratio of 0.75. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.75, BCOV is not doing good in the industry: 88.61% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.75
Quick Ratio	0.75

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.45% over the past year.

BCOV shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.

Measured over the past years, BCOV shows a small growth in Revenue. The Revenue has been growing by 4.07% on average per year.

EPS 1Y (TTM)145.45%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-60%

Revenue 1Y (TTM)-0.22%

Revenue growth 3Y0.64%

Revenue growth 5Y4.07%

Sales Q2Q%-2.02%

3.2 Future

BCOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.74% yearly.

Based on estimates for the next years, BCOV will show a small growth in Revenue. The Revenue will grow by 0.01% on average per year.

EPS Next Y100%

EPS Next 2Y64.74%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-1.51%

Revenue Next 2Y0.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 89.00, the valuation of BCOV can be described as expensive.

BCOV's Price/Earnings is on the same level as the industry average.

BCOV is valuated expensively when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.

A Price/Forward Earnings ratio of 124.65 indicates a quite expensive valuation of BCOV.

The rest of the industry has a similar Price/Forward Earnings ratio as BCOV.

BCOV is valuated expensively when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	89
Fwd PE	124.65

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BCOV is on the same level as its industry peers.

BCOV's Price/Free Cash Flow is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	51.96
EV/EBITDA	23.8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as BCOV's earnings are expected to grow with 64.74% in the coming years.

PEG (NY)0.89

PEG (5Y)N/A

EPS Next 2Y64.74%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BCOV!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BRIGHTCOVE

NASDAQ:BCOV (2/3/2025, 8:15:51 PM)

After market: 4.45 0 (0%)

4.45

+0.01 (+0.23%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)11-04 2024-11-04/amc

Earnings (Next)02-20 2025-02-20/amc

Inst Owners70.58%

Inst Owner Change-6%

Ins Owners5.23%

Ins Owner Change-165.71%

Market Cap201.05M

Analysts45.71

Price Target4.54 (2.02%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)100%

Min EPS beat(2)56.43%

Max EPS beat(2)143.57%

EPS beat(4)4

Avg EPS beat(4)114.38%

Min EPS beat(4)56.43%

Max EPS beat(4)161.44%

EPS beat(8)6

Avg EPS beat(8)77.66%

EPS beat(12)10

Avg EPS beat(12)100.79%

EPS beat(16)14

Avg EPS beat(16)114.38%

Revenue beat(2)2

Avg Revenue beat(2)0.71%

Min Revenue beat(2)0.56%

Max Revenue beat(2)0.87%

Revenue beat(4)2

Avg Revenue beat(4)-0.15%

Min Revenue beat(4)-1.91%

Max Revenue beat(4)0.87%

Revenue beat(8)2

Avg Revenue beat(8)-1%

Revenue beat(12)6

Avg Revenue beat(12)-0.14%

Revenue beat(16)10

Avg Revenue beat(16)0.35%

PT rev (1m)0%

PT rev (3m)14.84%

EPS NQ rev (1m)0%

EPS NQ rev (3m)50%

EPS NY rev (1m)N/A

EPS NY rev (3m)100%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-0.39%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.25%

Valuation

		Industry Rank	Sector Rank
PE	89
Fwd PE	124.65
P/S	1.01
P/FCF	51.96
P/OCF	14.73
P/B	2.11
P/tB	11.84
EV/EBITDA	23.8

EPS(TTM)0.05

EY1.12%

EPS(NY)0.04

Fwd EY0.8%

FCF(TTM)0.09

FCFY1.92%

OCF(TTM)0.3

OCFY6.79%

SpS4.42

BVpS2.11

TBVpS0.38

PEG (NY)0.89

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.34%
ROE	-9.58%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	61.6%
FCFM	1.94%

ROA(3y)-4.02%

ROA(5y)-5.56%

ROE(3y)-9.19%

ROE(5y)-12.88%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.06%

GM growth 5Y0.65%

F-Score7

Asset Turnover0.95

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	50.16%
Cap/Sales	4.89%
Interest Coverage	N/A
Cash Conversion	186.6%
Profit Quality	N/A
Current Ratio	0.75
Quick Ratio	0.75
Altman-Z	0.08

F-Score7

WACC10.73%

ROIC/WACCN/A

Cap/Depr(3y)143.44%

Cap/Depr(5y)123.4%

Cap/Sales(3y)7.87%

Cap/Sales(5y)6.39%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)145.45%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-60%

EPS Next Y100%

EPS Next 2Y64.74%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.22%

Revenue growth 3Y0.64%

Revenue growth 5Y4.07%

Sales Q2Q%-2.02%

Revenue Next Year-1.51%

Revenue Next 2Y0.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y51.3%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year979.3%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y4.57%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-44.43%

OCF growth 3Y-40.43%

OCF growth 5Y12.05%

BRIGHTCOVE (BCOV) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens